Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.
Embryonic stem cells in multiple sclerosis.
Subject-Specific Sparse Dictionary Learning for Atlas-Based Brain MRI Segmentation.
Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis.
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
A new mechanism of nervous system plasticity: activity-dependent myelination.
How do autoimmune diseases cluster in families? A systematic review and meta-analysis.
Human Herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via TLR9.
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
Modification of the FoxP3 Transcription Factor Principally Affects Inducible T Regulatory Cells in a Model of Experimental Autoimmune Encephalomyelitis.
Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor.
Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life.
Nutraceuticals against Neurodegeneration: A Mechanistic Insight.
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: A 7 Tesla MRI study.
ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Sphingosine 1-phosphate signaling at the blood-brain barrier.
Human vaccines & immunotherapeutics: news.
Eight-and-a-half syndrome as presenting sign of childhood multiple sclerosis.

Pages